Your browser doesn't support javascript.
Moderators of a resiliency group intervention for frontline clinicians during the COVID-19 pandemic.
Sylvia, Louisa G; George, Nevita; Rabideau, Dustin J; Streck, Joanna M; Albury, Evan; Hall, Daniel L; Luberto, Christina M; Mizrach, Helen R; Perez, Giselle K; Crute, Sydney; Mehta, Darshan H; Convery, Mary Susan; Looby, Sara E; Fricchione, Gregory; Fava, Maurizio; Wilhelm, Sabine; Park, Elyse R.
  • Sylvia LG; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Dauten Family Center for Bipolar Treatment Innovation, Boston, MA, USA. Electronic address: lsylvia2@mgh.harvard.edu.
  • George N; Massachusetts General Hospital, Boston, MA, USA; Dauten Family Center for Bipolar Treatment Innovation, Boston, MA, USA.
  • Rabideau DJ; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Streck JM; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Albury E; Massachusetts General Hospital, Boston, MA, USA; Dauten Family Center for Bipolar Treatment Innovation, Boston, MA, USA.
  • Hall DL; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.
  • Luberto CM; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.
  • Mizrach HR; Massachusetts General Hospital, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.
  • Perez GK; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA.
  • Crute S; Massachusetts General Hospital, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.
  • Mehta DH; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA.
  • Convery MS; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA.
  • Looby SE; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Fricchione G; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA.
  • Fava M; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Wilhelm S; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Park ER; Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Benson-Henry Institute, Boston, MA, USA; Benson-Henry Institute for Mind Body Medicine, Boston, MA, USA.
J Affect Disord ; 293: 373-378, 2021 10 01.
Article in English | MEDLINE | ID: covidwho-1284165
ABSTRACT

BACKGROUND:

To mitigate the psychological burdens of COVID-19 for frontline clinicians (FCs), we adapted an existing evidence-based resiliency program, Stress Management and Resilience Training Relaxation Response Program (SMART-3RP), for FCs. This analysis explores moderators of stress coping to determine which subgroups of FCs benefited most from SMART-3RP.

METHODS:

102 FCs from Mass General Brigham hospitals engaged in the adapted SMART-3RP. Assessments were completed at group entry (Week 0) and completion (Week 4). The primary outcome was stress coping, and we examined 15 possible baseline moderators. We fit linear mixed effects regression models and assessed potential baseline moderators using a likelihood ratio test. We report model-based estimates and confidence intervals for each moderator-by-time interaction (i.e., differential effect), where positive/negative values indicate more/less improvement in average perceived stress coping.

RESULTS:

Stress coping improved from Week 0 to Week 4 (mean improvement [95% CI] = 0.9 [0.6 to 1.2]). FCs with higher anxiety (differential effect [95% CI] = 0.3 [0.1 to 0.4]), depression (0.4 [0.2 to 0.6]), and loneliness (0.4 [0.1 to 0.6]), but lower levels of mindfulness (CAMS-Rfocus 1.0 [0.4 to 1.6]; CAMS-Raccept 1.3 [0.7 to 2.0]) and self-compassion (0.4, [0.1 to 0.8]) at baseline experienced greater benefits in perceived stress coping from the SMART-3RP. Baseline health uncertainty along with sociodemographic and work characteristics did not moderate stress coping.

DISCUSSION:

Results highlight particular sub-populations of FCs that may benefit more from a stress management intervention, especially during emergency responses (e.g., COVID-19 pandemic).
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Resilience, Psychological / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: J Affect Disord Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Resilience, Psychological / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: J Affect Disord Year: 2021 Document Type: Article